A Double Blind, Placebo-Controlled Study of the Efficacy and Safety of CORLUX (Mifepristone) vs. Placebo in the Treatment of Psychotic Symptoms in Patients with Major depressive Disorder with Psychotic Features
|Effective start/end date||4/7/09 → 4/14/11|
- ICON CLINICAL RESEARCH, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.